Literature DB >> 22348199

Design and Rationale for the Study of Changes in Iron and Atherosclerosis Risk in Perimenopause.

Georgeta Mihai1, Xin He, Xiaolan Zhang, Beth McCarthy, Tam Tran, Michael Pennell, Jessica Blank, Orlando P Simonetti, Rebecca D Jackson, Subha V Raman.   

Abstract

This study seeks to investigate changes in iron homeostasis and carotid arteries in women at risk of atherosclerosis, addressing a relatively unexplored hypothesis explaining why women have a 5-10 year lag in initial atherosclerotic events. Recent evidence points to hepcidin, the key regulator of macrophage iron uptake and release, as a potential mediator of risk. Furthermore, iron catalyzes the generation of free radicals that oxidize cholesterol stimulating atheroma formation. Magnetic resonance imaging (MRI) is ideally suited to study iron because of iron's local effects on magnetic susceptibility that can be quantified using a relaxation parameter called T2* ('T2-star'), as well as the ability to noninvasively characterize and quantify atherosclerotic plaque with MRI. This work outlines the rationale and study design to provide critical evidence related to the iron hypothesis, such that novel diagnostics and therapeutics to attenuate risk may be derived from a better understanding of iron's role in atherosclerosis.

Entities:  

Year:  2011        PMID: 22348199      PMCID: PMC3279750          DOI: 10.4172/2155-9880.1000152

Source DB:  PubMed          Journal:  J Clin Exp Cardiolog


  25 in total

1.  Serum non-transferrin-bound iron and low-density lipoprotein oxidation in heterozygous hemochromatosis.

Authors:  Lambertus J H van Tits; Esther M G Jacobs; Dorine W Swinkels; Heidi L M Lemmers; Gerly M van der Vleuten; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Biochem Biophys Res Commun       Date:  2006-05-02       Impact factor: 3.575

2.  Blood donations and risk of coronary heart disease in men.

Authors:  A Ascherio; E B Rimm; E Giovannucci; W C Willett; M J Stampfer
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

3.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.

Authors:  Jodie L Babitt; Franklin W Huang; Diedra M Wrighting; Yin Xia; Yisrael Sidis; Tarek A Samad; Jason A Campagna; Raymond T Chung; Alan L Schneyer; Clifford J Woolf; Nancy C Andrews; Herbert Y Lin
Journal:  Nat Genet       Date:  2006-04-09       Impact factor: 38.330

4.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

5.  Risk factors that attenuate the female coronary disease advantage.

Authors:  W B Kannel; P W Wilson
Journal:  Arch Intern Med       Date:  1995-01-09

Review 6.  Hormone replacement therapy and stroke: clinical trials review.

Authors:  Lawrence M Brass
Journal:  Stroke       Date:  2004-09-30       Impact factor: 7.914

7.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

Review 8.  Macrophage iron, hepcidin, and atherosclerotic plaque stability.

Authors:  Jerome L Sullivan
Journal:  Exp Biol Med (Maywood)       Date:  2007-09

9.  Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease.

Authors:  M Miller; G M Hutchins
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

10.  Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women.

Authors:  Jennifer S Lee; Andrea Z LaCroix; LieLing Wu; Jane A Cauley; Rebecca D Jackson; Charles Kooperberg; Meryl S Leboff; John Robbins; Cora E Lewis; Douglas C Bauer; Steven R Cummings
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

View more
  4 in total

1.  Iron, inflammation and atherosclerosis risk in men vs. perimenopausal women.

Authors:  Subha V Raman; Travis P Sharkey-Toppen; Tam Tran; Jim X Liu; Beth McCarthy; Xin He; Suzanne Smart; Martha Gulati; Randell Wexler; Orlando P Simonetti; Rebecca D Jackson
Journal:  Atherosclerosis       Date:  2015-03-20       Impact factor: 5.162

2.  Magnetic resonance imaging biomarkers of exercise-induced improvement of oxidative stress and inflammation in the brain of old high-fat-fed ApoE-/- mice.

Authors:  Erica N Chirico; Vanessa Di Cataldo; Fabien Chauveau; Alain Geloën; David Patsouris; Benoît Thézé; Cyril Martin; Hubert Vidal; Jennifer Rieusset; Vincent Pialoux; Emmanuelle Canet-Soulas
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

3.  Iron and noncontrast magnetic resonance T2* as a marker of intraplaque iron in human atherosclerosis.

Authors:  Marshall W Winner; Travis Sharkey-Toppen; Xiaolan Zhang; Michael L Pennell; Orlando P Simonetti; Jay L Zweier; Patrick S Vaccaro; Subha V Raman
Journal:  J Vasc Surg       Date:  2014-03-24       Impact factor: 4.268

Review 4.  GRE T2∗-weighted MRI: principles and clinical applications.

Authors:  Meng Yue Tang; Tian Wu Chen; Xiao Ming Zhang; Xiao Hua Huang
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.